Cargando…
Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge
Statins, the 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors, are widely prescribed for treatment of hypercholesterolemia. Although statins are generally well tolerated, up to ten percent of statin-treated patients experience myalgia symptoms, defined as muscle pain without elevated creat...
Autores principales: | Elam, Marshall B., Majumdar, Gipsy, Mozhui, Khyobeni, Gerling, Ivan C., Vera, Santiago R., Fish-Trotter, Hannah, Williams, Robert W., Childress, Richard D., Raghow, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542661/ https://www.ncbi.nlm.nih.gov/pubmed/28771594 http://dx.doi.org/10.1371/journal.pone.0181308 |
Ejemplares similares
-
Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017) -
Epigenetic control of signaling networks involved in interleukin-18-induced cardiac hypertrophy and its attenuation by pan-histone deacetylase inhibitors
por: Majumdar, Gipsy, et al.
Publicado: (2010) -
A systems biology approach to elucidating epigenetic regulation of cardiac hypertrophy
por: Majumdar, Gipsy, et al.
Publicado: (2013) -
Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia
por: Ballard, Kevin D., et al.
Publicado: (2015) -
Statin-Related Necrotizing Autoimmune Myositis: More Than Myalgia
por: Scheuing, William J, et al.
Publicado: (2022)